Unither is a leading player in the development and manufacturing of easy-to-use dosage form solutions

The company is notably the world leader in blow-fill-seal (BFS) technology, which uses sterile unit doses to eliminate the need for preservatives. To best serve its customers, Unither operates six manufacturing sites in France, the United States and Brazil, and has a dedicated research and development center in Europe. Keensight Capital provided an equity investment to cash out existing shareholders and support the management team in the next steps of the company’s development.

Headquarter

FRANCE

Investment Year

2017

Status

CURRENT